Enasidenib mesylate

Gras, J

No Org, Catalonia, Spain.

DRUGS OF THE FUTURE, 2017; 42 (1): 15

Abstract

Acute myeloid leukemia (AML) is the most common acute leukemia affecting adults. The median age at diagnosis is 67 years, and 5-year relative survival......

Full Text Link